Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B.
Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B.
复制标题
HBV DNA 原位检测的临床相关性:慢性乙型肝炎患者的横断面研究
DOI:
10.1136/jclinpath-2020-206440
复制
发表时间:
2020-12
影响因子:
3.4
通讯作者:
Zhang Z
中科院分区:
文献类型:
--
作者:
Liu D;Xu T;Shi B;Lu W;Zheng Y;Feng Y;Yuan Z;Zhang X;Zhang Z
Aims The visualisation of HBV DNA in liver sections of patients with chronic hepatitis B (CHB) in our previous report uncovered a mosaic distribution of viral antigens and nucleic acids. Here we aim to further explore the clinical utility of the in situ hybridisation (ISH) assay for HBV DNA. Method ISH of HBV DNA along with immunohistochemistry (IHC) of HBsAg, HBcAg and routine histopathology analysis was performed in 313 treatment-naive patients with CHB. Serum HBcrAg and HBcAb titre were also measured in addition to basic biochemical and virological parameters. Results The ISH of HBV DNA, HBsAg and HBcAg showed 95.2%, 97.1% and 42.8% positive rate, respectively. The staining pattern of HBV DNA differs significantly with that of HBsAg. Intrahepatic HBV DNA exhibited high-level of correlations with viral load, HBcrAg and HBsAg titre. In HBeAg-negative patients, higher intrahepatic HBV DNA is associated with histological evidence of liver inflammation and fibrosis, whereas no such trend was observed in HBeAg-positive patients. Finally, a triple staining protocol that combined the detection of HBV DNA, HBsAg and collagen fibre was developed to enable better evaluation of viral replication and antigen expression in the context of disease progression. Conclusions The ISH assay for HBV DNA reflects the vigour of intrahepatic viral replication. It is complementary to the routine IHC assay for viral antigens and also related to the histopathological progression of liver diseases. The application of the HBV DNA ISH assay may help a better evaluation of virological and pathological condition of patients with CHB.
登录
查看更多内容
影响因子:
14.2
作者:
Song, L. -W.;Liu, P. -G.;Xia, N. -S.
通讯作者:
Xia, N. -S.
影响因子:
14.2
作者:
van Campenhout, M. J. H.;Brouwer, W. P.;Janssen, H. L. A.
通讯作者:
Janssen, H. L. A.
影响因子:
3.1
作者:
Zhang, Zhan-Qing;Lu, Wei;Feng, Yan-Ling
通讯作者:
Feng, Yan-Ling
影响因子:
6.6
作者:
Sarin SK;Kumar M;Lau GK;Abbas Z;Chan HL;Chen CJ;Chen DS;Chen HL;Chen PJ;Chien RN;Dokmeci AK;Gane E;Hou JL;Jafri W;Jia J;Kim JH;Lai CL;Lee HC;Lim SG;Liu CJ;Locarnini S;Al Mahtab M;Mohamed R;Omata M;Park J;Piratvisuth T;Sharma BC;Sollano J;Wang FS;Wei L;Yuen MF;Zheng SS;Kao JH
通讯作者:
Kao JH
影响因子:
2.4
作者:
Zhang ZQ;Zhang XN;Lu W;Wang YB;Weng QC;Feng YL
通讯作者:
Feng YL